Effects of cycling and rowing on serum concentrations of prostate-specific antigen: A randomized study of 101 male subjects

Prostate. 2022 May;82(7):804-808. doi: 10.1002/pros.24322. Epub 2022 Feb 22.

Abstract

Objective: To determine the effects if cycling and rowing on serum prostate-specific antigen (PSA) levels.

Methods: Male volunteers (n = 101), aged 20-80 (mean, 49.9) years were randomized to exercise at the first or second study visit. They performed 1 h of either cycling or rowing on a stationary machine. To determine exercise-induced effects on the PSA level, serum total PSA (tPSA) and free PSA (fPSA) concentrations were evaluated before and after exercise and another sampling was performed at the second study visit. Pre-exercise and postexercise tPSA and fPSA concentrations were compared using the Wilcoxon matched-pairs test. The results were analyzed using the Mann-Whitney U-test.

Results: A significant (p < 0.001) average increase in tPSA after exercise (1.14 ± 1.11 ng/ml to 1.24 ± 1.26 ng/ml [mean, +8.8%]) was observed after both cycling and rowing, without significant differences between the sports (p = 0.54). The exercise-induced increase in PSA concentration affected participants aged ≥50 years (difference, 0.16 ± 0.37; p < 0.001), but not those aged <50 years (difference, 0.01 ± 0.06; p = 0.23). The effect size was clinically irrelevant in all except two outliers, in whom a distinct increase of PSA level by averages of 1.80 ng/ml (+55%) for tPSA and 1.25 ng/ml (+227%) for fPSA following cycling was observed.

Conclusion: Rowing and cycling generally do not have a clinically relevant effect on PSA levels. However, outliers exist. Our findings do not support abstaining from exercise during the days approaching PSA sampling.

Keywords: cycling; physical activity; prostate cancer diagnosis; prostate-specific antigen; rowing.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Exercise
  • Humans
  • Male
  • Prostate-Specific Antigen
  • Prostatic Neoplasms*
  • Water Sports*

Substances

  • Prostate-Specific Antigen